Clinical trial
The Effect of Ranolazine on Cardiac Arrhythmias and Microvolt T- Wave Alternans in Patients With Significant Left Ventricular Dysfunction
NCT00998218 is registered in ClinicalTrials.gov with Aspirus Heart and Vascular Institute-Research and Education as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Ranolazine on Cardiac Arrhythmias and Microvolt T- Wave Alternans in Patients With Significant Left Ventricular Dysfunction
- Lead sponsor
- Aspirus Heart and Vascular Institute-Research and Education
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 30, 2009
- Completion date
- December 31, 2010
- Enrollment
- 7 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
sudden cardiac death, ventricular arrythmias